IL21 and ovarian carcinoma: A statistically significantly lower concentration of IL-21 in the serum of women with ovarian cancer was demonstrated compared to the concentration in the control group (p < 0.001), where Q1 and Q3 were respectively: 722.19 and 909.60 with a median of 793.59 pg/mL.